PBH

Prestige Consumer Healthcare Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →

YES
8.2% BELOW
↓ Approaching Was -7.5% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $66.44
14-Week RSI 49
Rel. Volume (14w) This week's trading vs. the 14-week average 1.8x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.86

Prestige Consumer Healthcare Inc. (PBH) closed at $60.99 as of 2026-03-20, trading 8.2% below its 200-week moving average of $66.44. This places PBH in the deep value zone. The stock is currently moving closer to the line, down from -7.5% last week. The 14-week RSI sits at 49, indicating neutral momentum.

Trading volume is running at 1.8x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.86 ratio) is neutral — neither side is clearly dominating.

Over the past 1053 weeks of data, PBH has crossed below its 200-week moving average 14 times. On average, these episodes lasted 30 weeks. Historically, investors who bought PBH at the start of these episodes saw an average one-year return of +21.0%.

With a market cap of $2.9 billion, PBH is a mid-cap stock. The company generates a free cash flow yield of 7.1%, which is healthy. Return on equity stands at 10.3%. The stock trades at 1.6x book value.

Over the past 20.2 years, a hypothetical investment of $100 in PBH would have grown to $478, compared to $739 for the S&P 500. PBH has returned 8.0% annualized vs 10.4% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: PBH vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After PBH Crosses Below the Line?

Across 13 historical episodes, buying PBH when it crossed below its 200-week moving average produced an average return of +17.5% after 12 months (median -1.0%), compared to +10.9% for the S&P 500 over the same periods. 45% of those episodes were profitable after one year. After 24 months, the average return was +43.1% vs +13.6% for the index.

Each line shows $100 invested at the moment PBH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

PBH has crossed below its 200-week MA 14 times with an average 1-year return of +21.0% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jan 2006Apr 20076537.8%+3.0%+392.6%
Apr 2007May 200743.5%-31.3%+370.6%
Jun 2007Jun 200710.4%-17.5%+371.7%
Jul 2007Apr 201014262.0%-21.1%+386.0%
May 2010Sep 20101920.2%+55.9%+672.0%
Aug 2011Aug 201114.1%+97.6%+628.7%
Nov 2011Nov 201115.1%+149.9%+626.1%
Oct 2017Dec 201759.4%-12.2%+41.9%
Dec 2017Feb 202011140.6%-32.9%+36.9%
Feb 2020May 20201227.4%+11.6%+63.2%
Jun 2020Jan 20213316.7%+28.4%+51.3%
Aug 2025Aug 202510.8%N/A-6.2%
Sep 2025Feb 2026229.6%N/A-6.2%
Mar 2026Ongoing2+8.2%Ongoing-0.7%
Average30+21.0%

Frequently Asked Questions

Is PBH below its 200-week moving average?

Yes. As of 2026-03-20, Prestige Consumer Healthcare Inc. (PBH) is trading 8.2% below its 200-week moving average of $66.44. The current price is $60.99.

What is PBH's 200-week moving average price?

Prestige Consumer Healthcare Inc.'s 200-week moving average is $66.44 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when PBH drops below its 200-week moving average?

PBH has crossed below its 200-week moving average 14 times in our data. On average, buying at that moment produced a one-year return of +21.0%. These dips have historically been decent entry points. These episodes lasted 30 weeks on average.

Is PBH a good value right now?

Here's what our data says about PBH as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 49. Free cash flow yield is 7.1%. Return on equity is 10.3%. Price-to-book is 1.6x. This is not a buy or sell recommendation — always do your own research.

How does PBH compare to the S&P 500?

Over the past 20.2 years, $100 invested in PBH would have grown to $478, compared to $739 for the S&P 500. That's 8.0% annualized vs 10.4% for the index. PBH has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20